Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. This was a randomized phase III study to test ...
Beta-tubulin III isotype expression and response to anti-tubulin therapy in metastatic breast cancer (MBC) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback